Michael Secora serves as Executive at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Michael Secora has executed 90 insider transactions totaling $6.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 11, 2024 involved exercising options for 39,375 shares valued at $87.4K.
Michael Secora currently holds 1,417,131 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Secora has been a net seller of RXRX stock. They have purchased $0 and sold $6.0M worth of shares.
Michael Secora's most recent insider trade was on Sep 11, 2024, when they sold 39,375 shares at $2.22 per share.
Get notified when new Form 4 filings are submitted
| $6.32 |
| Planned |
| Sep 10, 2024 | RXRX | $87.4K | Option Exercise | 39,375 | $2.22 | Planned |
| Sep 10, 2024 | RXRX | $92.5K | Sale | 15,000 | $6.17 | Planned |
| Aug 15, 2024 | RXRX | $80.0K | Payment | 11,962 | $6.69 | Discretionary |
| Aug 14, 2024 | RXRX | $87.4K | Option Exercise | 39,375 | $2.22 | Planned |
| Aug 14, 2024 | RXRX | $95.3K | Sale | 15,000 | $6.35 | Planned |
| Aug 13, 2024 | RXRX | $95.3K | Sale | 15,000 | $6.35 | Planned |
| Aug 13, 2024 | RXRX | $87.4K | Option Exercise | 39,375 | $2.22 | Planned |
| Jul 10, 2024 | RXRX | $108.6K | Sale | 15,000 | $7.24 | Planned |
| Jul 10, 2024 | RXRX | $87.4K | Option Exercise | 39,375 | $2.22 | Planned |
| Jul 9, 2024 | RXRX | $109.8K | Sale | 15,000 | $7.32 | Planned |
| Jul 9, 2024 | RXRX | $87.4K | Option Exercise | 39,375 | $2.22 | Planned |
| Jun 14, 2024 | RXRX | $87.4K | Option Exercise | 39,375 | $2.22 | Planned |
| Jun 14, 2024 | RXRX | $139.1K | Sale | 15,000 | $9.27 | Planned |
| Jun 13, 2024 | RXRX | $87.4K | Option Exercise | 39,375 | $2.22 | Planned |
| Jun 13, 2024 | RXRX | $139.8K | Sale | 15,000 | $9.32 | Planned |
| May 15, 2024 | RXRX | $119.7K | Payment | 11,962 | $10.01 | Discretionary |
| Apr 17, 2024 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Apr 17, 2024 | RXRX | $175.3K | Sale | 23,124 | $7.58 | Planned |
| Apr 16, 2024 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Apr 16, 2024 | RXRX | $191.8K | Sale | 25,000 | $7.67 | Planned |
| Mar 13, 2024 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Mar 13, 2024 | RXRX | $275.8K | Sale | 25,000 | $11.03 | Planned |
| Mar 12, 2024 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Mar 12, 2024 | RXRX | $261.5K | Sale | 25,000 | $10.46 | Planned |
| Feb 15, 2024 | RXRX | $89.1K | Payment | 7,172 | $12.43 | Discretionary |
| Feb 14, 2024 | RXRX | $11.7K | Sale | 1,067 | $10.98 | Planned |
| Feb 14, 2024 | RXRX | $249.6K | Sale | 23,933 | $10.43 | Planned |
| Feb 14, 2024 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |